Studies on the fatty acid inactivation of phosphofructokinase.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 127797)

Published in J Biol Chem on January 10, 1976

Authors

C S Ramadoss, K Uyeda, J M Johnston

Articles by these authors

(truncated to the top 100)

A special fructose bisphosphate functions as a cytoplasmic regulatory metabolite in green leaves. Proc Natl Acad Sci U S A (1982) 4.80

A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A (2001) 4.73

Developing behavior analysis at the state level. Behav Anal (1987) 4.17

Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A (2001) 3.57

Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology (2001) 2.99

Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet (1969) 2.53

Phosphofructokinase. Adv Enzymol Relat Areas Mol Biol (1979) 2.48

Origin of immunoreactive lymphocytes in rats. Cell Immunol (1970) 2.30

The relation of food quantity to rumination behavior. J Appl Behav Anal (1981) 2.23

Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol (2000) 2.04

Hormone-stimulated phosphorylation of liver phosphofructokinase in vivo. J Biol Chem (1979) 1.74

Punishment of human behavior. Am Psychol (1972) 1.71

Distinguishing between applied research and practice. Behav Anal (1996) 1.67

An activation factor of liver phosphofructokinase. Proc Natl Acad Sci U S A (1980) 1.60

Pyruvate-ferredoxin oxidoreductase. 3. Purification and properties of the enzyme. J Biol Chem (1971) 1.60

The effect of natural and synthetic D-fructose 2,6-bisphosphate on the regulatory kinetic properties of liver and muscle phosphofructokinases. J Biol Chem (1981) 1.51

Platelet-activating factor in surfactant preparations. Lancet (1993) 1.48

Regulatory mechanisms in carbohydrate metabolism. VII. Hexokinase and phosphofructokinase. J Biol Chem (1965) 1.47

A prospective study of back belts for prevention of back pain and injury. JAMA (2000) 1.46

Cholera on a Gulf Coast oil rig. N Engl J Med (1983) 1.42

On the relation between generalization and generality. Behav Anal (1979) 1.42

Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41

Vibrio vulnificus. Man and the sea. JAMA (1985) 1.35

Molecular cloning, sequence analysis, and expression of a human liver cDNA coding for fructose-6-P,2-kinase:fructose-2,6-bisphosphatase. Biochem Biophys Res Commun (1988) 1.33

The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domain homologies. Structure (1996) 1.30

Glucose-stimulated synthesis of fructose 2,6-bisphosphate in rat liver. Dephosphorylation of fructose 6-phosphate, 2-kinase:fructose 2,6-bisphosphatase and activation by a sugar phosphate. J Biol Chem (1994) 1.29

A parametric analysis of the relationship between food quantity and rumination. J Exp Anal Behav (1984) 1.27

A novel factor binding to the glucose response elements of liver pyruvate kinase and fatty acid synthase genes. J Biol Chem (1999) 1.27

Enzymes of clostridial purine fermentation. Methylenetetrahydrofolate dehydrogenase. J Biol Chem (1967) 1.27

Gastroenteritis in patients with stool isolates of Vibrio vulnificus. Am J Med (1986) 1.27

A binding study of the interaction of beta-D-fructose 2,6-bisphosphate with phosphofructokinase and fructose-1,6-bisphosphatase. J Biol Chem (1983) 1.25

Depressive symptoms, cognitive impairment and functional impairment in a rural elderly population in India: a Hindi version of the geriatric depression scale (GDS-H). Int J Geriatr Psychiatry (1999) 1.24

Physical studies on assimilatory nitrate reductase from Chlorella vulgaris. J Biol Chem (1979) 1.24

Effects of nutritional and mechanical properties of food on ruminative behavior. J Exp Anal Behav (1985) 1.23

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints. Aliment Pharmacol Ther (2012) 1.22

Disease from infection with Vibrio mimicus, a newly recognized Vibrio species. Clinical characteristics and edipemiology. Ann Intern Med (1983) 1.21

Changes in the concentration of activation factor for phosphofructokinase in hepatocytes in response to glucose and glucagon. Biochem Biophys Res Commun (1980) 1.21

Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase. J Biol Chem (1995) 1.20

Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J Neurosci Res (1996) 1.20

Fructose-2,6-P2, chemistry and biological function. Mol Cell Biochem (1982) 1.20

Regulation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation: possible mechanism for coordinated control of glycolysis and glycogenolysis. Proc Natl Acad Sci U S A (1982) 1.19

Second-order schedules: a comparison of chained, brief-stimulus, and tandem procedures. J Exp Anal Behav (1973) 1.18

The interaction of phosphofructokinase with erythrocyte membranes. J Biol Chem (1979) 1.18

Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2,6-bisphosphate and ribose 1,5-bisphosphate. J Biol Chem (2001) 1.16

Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells. J Virol (1985) 1.15

Changes in allosteric properties of phosphofructokinase bound to erythrocyte membranes. J Biol Chem (1977) 1.15

Small head size is related to low Mini-Mental State Examination scores in a community sample of nondemented older adults. Neurology (1999) 1.14

The structure of "activation factor" for phosphofructokinase. J Biol Chem (1981) 1.13

Studies on the reaction mechanism of skeletal muscle phosphofructokinase. J Biol Chem (1970) 1.12

Inland presentation of Vibrio vulnificus primary septicemia and necrotizing fasciitis. West J Med (1986) 1.12

Disease from infection with Vibrio mimicus, a newly recognized Vibrio species. Ann Intern Med (1983) 1.11

Phosphorylation of myocardial fructose-6-phosphate,2-kinase: fructose-2,6-bisphosphatase by cAMP-dependent protein kinase and protein kinase C. Activation by phosphorylation and amino acid sequences of the phosphorylation sites. J Biol Chem (1988) 1.09

Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes. J Immunol (1979) 1.07

Biosynthesis of a prostaglandin by a plant enzyme. J Biol Chem (1978) 1.07

Molecular cloning of the DNA and expression and characterization of rat testes fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase. J Biol Chem (1991) 1.06

Regulatory mechanisms in carbohydrate metabolism. 8. The regulatory function of phosphate in glycolysis. J Biol Chem (1965) 1.05

Regulation of phosphofructokinase by a new mechanism. An activation factor binding to phosphorylated enzyme. J Biol Chem (1980) 1.04

Reaction of phosphofructokinase with maleic anhydride, succinic anhydride, and pyridoxal 5'-phosphate. Biochemistry (1969) 1.04

Strategic and tactical limits of comparison studies. Behav Anal (1988) 1.04

Age-period-cohort analysis of tuberculosis notifications in Hong Kong from 1961 to 2005. Thorax (2007) 1.03

Vibrio vulnificus. A gastronomic hazard. JAMA (1983) 1.02

A mechanism for fatty acid inhibition of glucose utilization in liver. Role of xylulose 5-P. J Biol Chem (1996) 1.02

Regulation of fructose 2,6-P2 concentration in isolated hepatocytes. Biochem Biophys Res Commun (1981) 1.02

Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci (1994) 1.02

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study. Br J Rheumatol (1996) 1.01

The tissue distribution of fructose-2,6-p2 and fructose-6-P,2-kinase in rats and the effect of starvation diabetes and hypoglycemia on hepatic fructose-2,6-P2 and fructose-6-P,2-kinase. Biochem Biophys Res Commun (1982) 1.01

Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim Biophys Acta (1966) 1.01

Identifying barriers to the adoption of evidence-based medicine practice in clinical clerks: a longitudinal focus group study. Med Educ (2004) 1.01

Bovine heart fructose-6-phosphate 2-kinase/fructose-2,6-bisphosphatase: complete amino acid sequence and localization of phosphorylation sites. Proc Natl Acad Sci U S A (1990) 1.01

Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients. Rheumatology (Oxford) (2000) 1.00

The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials. Aliment Pharmacol Ther (2014) 1.00

Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor. Neuroreport (1998) 1.00

The synthesis of higher glycerides via the monoglyceride pathway in hamster adipose tissue. J Lipid Res (1971) 0.99

Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins. J Lipid Res (1997) 0.99

Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology (1996) 0.99

Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial. Rheumatology (Oxford) (2002) 0.98

Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women. Endocr Res (1994) 0.98

Computerization of clinical practice in Hong Kong. Int J Med Inform (2001) 0.98

Differences in kinetic properties of phospho and dephospho forms of fructose-6-phosphate, 2-kinase and fructose 2,6-bisphosphatase. J Biol Chem (1984) 0.98

Pyruvate-ferredoxin oxidoreductase. IV. Studies on the reaction mechanism. J Biol Chem (1971) 0.98

Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report. J Pediatr Gastroenterol Nutr (1994) 0.98

Effects of premeal chewing on ruminative behavior. Am J Ment Retard (1988) 0.98

The mechanism of activation of heart fructose 6-phosphate,2-kinase:fructose-2,6-bisphosphatase. J Biol Chem (1987) 0.98

A rapid procedure for the isolation, identification and estimation of citrinin. Anal Biochem (1973) 0.97

Studies of the formation and utilization of bound CoA in glyceride biosynthesis. Biochim Biophys Acta (1967) 0.96

Dopamine, the dopamine D2 receptor and pituitary tumours. Clin Endocrinol (Oxf) (1991) 0.96

Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. Am J Obstet Gynecol (1990) 0.95

Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. Am J Obstet Gynecol (1981) 0.95

Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res (1992) 0.94

Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proc Natl Acad Sci U S A (1988) 0.94

Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol (2000) 0.94

CMP-dependent incorporation of [14C]Glycerol 3-phosphate into phosphatidylglycerol and phosphatidylglycerol phosphate by rabbit lung microsomes. Biochim Biophys Acta (1982) 0.94

Initiation of human parturition. I. Mechanism of action of arachidonic acid. Obstet Gynecol (1974) 0.94

Enzymes of the clostridial purine fermentation. Serine hydroxymethyltransferase. Arch Biochem Biophys (1968) 0.94

The separation of the alpha-glycerophosphate and monoglyceride pathways in the intestinal biosynthesis of triglycerides. Biochim Biophys Acta (1967) 0.93

The use of interferon-alpha in virus infections. Drugs (1991) 0.93

A prospective longitudinal study of the release of oxytocin and prolactin in response to infant suckling in long term lactation. J Clin Endocrinol Metab (1986) 0.93

Phospholipid biosynthesis in lung lamellar bodies. Biochem Biophys Res Commun (1975) 0.93

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection. Arthritis Rheum (1995) 0.93

Serological response of cattle after vaccination and challenge with Brucella abortus. Vet Microbiol (1982) 0.93